Analysis of the molecular landscape that characterises a patient or disease is an evolving area that is increasingly driving discoveries in healthcare.
Paragon, as the name suggests, is a model of scientific and creative excellence, consistent in its pursuit of perfection. Drawing on a broad base of industry experience, the Paragon team delivers a comprehensive range of tailored medical communication solutions.
Always adaptable to client needs and constantly innovative in approach, Paragon creates best-in-class solutions to every challenge. Paragon works best as a seamless extension of your team, going beyond partnership to become a true stakeholder in your success; helping to shoulder the hard work in achieving the project goal.
Mantra.
Be different, be perfect, be excellent
Recent Highlights.
Comprehensive medical strategy and plan for landmark study
Series of visually impactful internal training materials
Congress, symposia and advisory board management at major oncology meetings
Real world evidence publication plan and delivery
Live and on-demand Webinar series
Vacancies.
We’re always looking for brilliant people to join our teams! Click the link to find out more about becoming part of Prime Global, view available roles, and apply.
Interesting Challenges.
Random Fact.
We currently work with clients and external experts spanning several continents and time zones from the east to west coast of America to Europe and Asia.
News.
-
Evolving applications of omics in healthcare
Prime Global 25 May, 2022Evolving applications of omics in healthcareread more >> -
Haemophilia awareness: building trusted relationships between patients and industry
Prime Global 19 April, 2022Haemophilia awareness: building trusted relationships between patients and industryread more >>Haemophilia is a lifelong genetic disorder characterised by excessive bleeding.(1) Despite the existence of treatments for haemophilia, the condition continues to have major impacts on quality of life, for example in the areas of pain (acute and chronic), joint mobility, and physical function.(1) To mark World Haemophilia Day on 17 April, Prime Patient partnered with sister agency HCD Economics, a consultancy specialising in haemophilia patient research, and haemophilia advocate Laurence Woollard to better understand the existing relationship between patients and industry and how meaningful improvements can be made to the lives of people living with haemophilia (PwH).
-
What do developmental disability advocates want Pharma to know?read more >>Prime Patient team up with Jess Duggan from the SynGAP Research Fund to better understand what this advocacy group wants Pharma to know this Developmental Disabilities Awareness Month.
Get in touch.
We’re always happy to hear from you
Use the contact form or get full details for each of our offices around the world.
Contact us